Clinical trial
Rapid Molecular Detection of Sepsis in Whole Blood
NCT06624618 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Rapid Molecular Detection of Sepsis in Whole Blood
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 1, 2024
- Completion date
- December 18, 2025
- Enrollment
- 300 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
bloodstream infection, sepsis